Effective Achievement of Hemoglobin Stability with Once-Monthly C.E.R.A. in Peritoneal Dialysis Patients: A Prospective Study

被引：0
|
作者：
Michael Koch
Wolfgang Treiber
Danilo Fliser
机构：
[1] Nephrology Center,Department of Internal Medicine IV
[2] Renal and Hypertension Center Mittelrhein,undefined
[3] Saarland University,undefined
[4] Medical Centre,undefined
来源：
Clinical Drug Investigation | 2013年 / 33卷
关键词：
Peritoneal Dialysis; Hemodialysis Patient; Peritoneal Dialysis Patient; Darbepoetin Alfa; Erythropoiesis Stimulate Agent;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：699 / 706
页数：7
相关论文
共 39 条
  • [11] C.E.R.A. once every 4 weeks corrects anaemia and maintains haemoglobin in patients with chronic kidney disease not on dialysis
    Roger, Simon D.
    Locatelli, Francesco
    Woitas, Rainer P.
    Laville, Maurice
    Tobe, Sheldon W.
    Provenzano, Robert
    Golper, Thomas A.
    Ruangkanchanasetr, Prajej
    Lee, Ho Yung
    Wu, Kwan-Dun
    Nowicki, Michal
    Agnes Ladanyi
    Martinez-Castelao, Alberto
    Beyer, Ulrich
    Dougherty, Frank C.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (12) : 3980 - 3986
  • [12] Subcutaneous (SC) C.E.R.A. (continuous erythropoietin receptor activator) administered once every 2 weeks or once monthly maintains haemoglobin (HB) levels in patients with chronic kidney disease (CKD) on dialysis
    Sulowicz, Wladyslaw
    Locatelli, Francesco
    Balla, Jozef
    Csiky, Botond
    Rikker, Casba
    Aldigier, Jean-Claude
    Dougherty, Frank C.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 156 - 157
  • [13] Conversion from Epoetin and Darbepoetin to C.E.R.A. in Non-Dialysis CKD Patients: A Multicenter Italian Prospective Study in Nephrology Practice
    Minutolo, Roberto
    Conte, Giuseppe
    Cozzolino, Mario
    Polito, Pasquale
    Manno, Carlo
    Di Iorio, Biagio R.
    Santoro, Domenico
    Di Luca, Marina
    Nappi, Felice
    Feriozzi, Sandro
    Sasso, Ferdinando C.
    De Nicola, Luca
    BLOOD PURIFICATION, 2013, 36 (02) : 69 - 77
  • [14] Darbepoetin alfa (KRN321) administered intravenously once monthly maintains hemoglobin levels in peritoneal dialysis patients
    Hiramatsu, Makoto
    Kubota, Minoru
    Iwasaki, Manabu
    Akizawa, Tadao
    Koshikawa, Shozo
    THERAPEUTIC APHERESIS AND DIALYSIS, 2008, 12 (01) : 19 - 27
  • [15] Relationship Between Peritoneal Protein Clearance and Hemoglobin in Peritoneal Dialysis Patients: A Prospective Cohort Study
    Ye, Hongjian
    Lin, Jianxiong
    Zhang, Xiaodan
    Chen, Wei
    Mao, Haiping
    Li, Jianying
    Yu, Xueqing
    Yang, Xiao
    JOURNAL OF RENAL NUTRITION, 2023, 33 (03) : 482 - 489
  • [16] Initial use of once-monthly administration of CERA is effective and safe in correcting renal anemia in non-dialysis patients: the MERCUR trial
    Koch, Michael
    Henrich, Dirk
    Faust, Justus
    Nawka, Jan
    Rath, Thomas
    Wanner, Christoph
    CLINICAL NEPHROLOGY, 2012, 78 (03) : 189 - 197
  • [17] Reticulocyte dynamic and hemoglobin variability in hemodialysis patients treated with Darbepoetin alfa and C.E.R.A.: a randomized controlled trial
    Valentina Forni
    Giorgia Bianchi
    Adam Ogna
    Igor Salvadé
    Philippe Vuistiner
    Michel Burnier
    Luca Gabutti
    BMC Nephrology, 14
  • [18] Pharmacokinetics of C. E. R. A. and stable maintenance of haemoglobin (HB) levels with once-monthly dosing in patients with chronic kidney disease (CKD)
    Chanu, Pascal
    Gieschke, Ronald
    Reigner, Bruno
    Dougherty, Frank C.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 342 - 342
  • [19] Hemoglobin Stability and Patient Compliance With Darbepoetin Alfa in Peritoneal Dialysis Patients After the Implementation of the Prospective Payment System
    Pirkle, James L., Jr.
    Paoli, Carly J.
    Russell, Greg
    Petersen, Jeffrey
    Burkart, John
    CLINICAL THERAPEUTICS, 2014, 36 (11) : 1665 - 1674
  • [20] Once-monthly subcutaneous CERA maintains stable hemoglobin control in patients with chronic kidney disease on dialysis and converted directly from epoetin one to three times weekly
    Sulowicz, Wladyslaw
    Locatelli, Francesco
    Ryckelynck, Jean-Philippe
    Balla, Jozsef
    Csiky, Botond
    Harris, Kevin
    Ehrhard, Patricia
    Beyer, Ulrich
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 2 (04): : 637 - 646
1234